BackThe Hydration Pharmaceuticals Company Limited Overview
The Hydration Pharmaceuticals Company Limited

The Hydration Pharmaceuticals Company Limited Return on Equity

Latest ROE for The Hydration Pharmaceuticals Company Limited: 282.93% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

282.93%

Return on Equity

282.93%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

The Hydration Pharmaceuticals Company Limited (HPC.AX) FAQ

The latest ROE for HPC.AX is 282.93%. That is above the sector sector average of 11.64%. Investors often review this figure alongside The Hydration Pharmaceuticals Company Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, HPC.AX currently prints 282.93% for ROE, while the sector average sits near 11.64%. That is roughly 2331.4% above the sector mean. Large gaps often invite a closer look at The Hydration Pharmaceuticals Company Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively The Hydration Pharmaceuticals Company Limited converts resources into returns. At 282.93%, HPC.AX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HPC.AX's ROE (282.93%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.